Healthcare Capital Corp. (HCCC) to Combine with Alpha Tau in $650M Deal

Healthcare Capital Corp. (NASDAQ:HCCC) has entered into a definitive agreement to combine with cancer drug developer Alpha Tau at an enterprise value of $650 million. Jerusalem-based Alpha Tau is developing unique cancer treatments that utilize alpha radiation to attack tumors with reduced damage to surrounding tissues and cells. The combined company is expected to trade
Read More